03 Jul Unleashing Innovation: report released on the London Life Sciences Sector’s fight against COVID-19
The UK #LifeSciences sector has responded rapidly to #COVID19, leading the way in research, innovation and collaboration. Our new #UnleashingInnovation brochure explores the extraordinary research that has taken place in London – read the report here: https://t.co/PxHVTKctvC pic.twitter.com/uRBd1Qdijd
— MedCity (@MedCityHQ) June 30, 2020
You will have heard the COVID-19 pandemic referred to as a “challenging time” in no amount of TV ads during the lockdown. But in the life sciences sector every challenge comes with opportunity. to demonstrate the sheer breadth of expertise and innovation in the UK, and in this COVID-19 is no different.
In London, the life sciences cluster has worked together in an unprecedented way to tackle the COVID-19 outbreak, which has inspired innovations and collaborations between institutions, the NHS and the private sector. The quality of the research stands by itself, as demonstrated in the above infographic: 37 high priority PHE studies across London, two potentially game-changing vaccine trials in progress, along with a number of other impressive achievements.
OVID Health is delighted to have advised and supported client MedCity capture some of the incredible COVID-19 medical science research happening in London in their report Unleashing Innovation. The report provides a snapshot and showcase of the very best R&D taking place in the capital, helping to cement the UK as a global science superpower.
Unleashing Innovation shares some of the world-leading science taking place across London in: vaccine development; diagnostics and testing; treatment; data, disease modelling and genomics. You can read Unleashing Innovation through the link provided.